Switch to:
GuruFocus has detected 2 Warning Signs with Alexion Pharmaceuticals Inc $ALXN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Alexion Pharmaceuticals Inc (NAS:ALXN)
Cash Flow from Financing
$-433 Mil (TTM As of Mar. 2017)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2017, Alexion Pharmaceuticals Inc paid $21 Mil more to buy back shares than it received from issuing new shares. It spent $44 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0 Mil from paying cash dividends to shareholders. It spent $4 Mil on other financial activities. In all, Alexion Pharmaceuticals Inc spent $69 Mil on financial activities for the three months ended in Mar. 2017.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Alexion Pharmaceuticals Inc's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

Cash from Financing(A: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-430+-375+0+0+-31
=-836

Alexion Pharmaceuticals Inc's Cash from Financing for the quarter that ended in Mar. 2017 is

Alexion Pharmaceuticals Inc Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2017 was -18.35 (Jun. 2016 ) + -62.187 (Sep. 2016 ) + -283.463 (Dec. 2016 ) + -69 (Mar. 2017 ) = $-433 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Alexion Pharmaceuticals Inc's net issuance of stock for the three months ended in Mar. 2017 was $-21 Mil. Alexion Pharmaceuticals Inc paid $21 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Alexion Pharmaceuticals Inc's net issuance of debt for the three months ended in Mar. 2017 was $-44 Mil. Alexion Pharmaceuticals Inc spent $44 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Alexion Pharmaceuticals Inc's net issuance of preferred for the three months ended in Mar. 2017 was $0 Mil. Alexion Pharmaceuticals Inc paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Alexion Pharmaceuticals Inc's cash flow for dividends for the three months ended in Mar. 2017 was $0 Mil. Alexion Pharmaceuticals Inc received $0 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Alexion Pharmaceuticals Inc's other financing for the three months ended in Mar. 2017 was $-4 Mil. Alexion Pharmaceuticals Inc spent $4 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Alexion Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Net Issuance of Stock 47293100451-66-303-328-430
Net Issuance of Debt 18-0-4400149-36-553,399-375
Net Issuance of Preferred 0000000000
Dividends 0000000000
Other Financing -0-0-10067174365-86-31
Cash from Financing 6528-1439396667272,985-836

Alexion Pharmaceuticals Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Net Issuance of Stock -20-35-17-73-203-293-18-61-58-21
Net Issuance of Debt -12-123,4550-44-175000-44
Net Issuance of Preferred 0000000000
Dividends 0000000000
Other Financing 152-91-11266-4-0-1-226-4
Cash from Financing -3053,346-185-181-472-18-62-283-69
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK